The Future of Colon Cancer Treatment

Colon cancer will affect 1 in 20 Americans in their lifetime. So how effective is chemotherapy for colon cancer? And perhaps more importantly, what's the latest in colon cancer treatment?

The headlines stemming from colon cancer treatment and prevention are abundant these days. From one source (medicalnewstoday.com) in the past month alone, there are news stories with headlines like, "…scientists patent an effective drug for treating breast, colon, and skin cancers," and "Newly identified biomarker may help predict colon cancer progression, personalize therapy."So how do you break through the hype to what is truly breaking news in the prevention and treatment for colon cancer today?

Perhaps the most promising treatment is immunotherapy for colon cancer. Immunotherapy uses a patient's own immune system to fight cancer—something that is proving successful in treating many types of cancers including melanoma, kidney cancer and lung cancer in study after study.

There are two types of immunotherapy for colon cancer and other types of cancer: active immunotherapy, which trains naturally occurring antibodies within the immune system to identify cancer cells as harmful, and to attack them; and passive immunotherapy, which uses lab-engineered monoclonal antibodies to kill cancer cells. Both types spare perfectly healthy cells, unlike today's chemotherapy for colon cancer.

"Chemotherapy has come a long way in treating colon cancer, "said Dr. Jorge Perez of Sierra Nevada Cancer Center in Carson City, Nevada. "But treatment innovation is important. I'm excited to explore the possibilities of immunotherapy."

Scientists are working diligently to prove that immunotherapy for colon cancer is more targeted and more successful than chemotherapy for colon cancer, and with fewer side effects, too.

Immunotherapy for colon cancer is still in the early phases of clinical testing. However, successes in the study of immunotherapy in other cancers are giving doctors and patients new hope for curing and preventing colon cancer in our lifetime.

The contrast is undeniable between immunotherapy and the current options for treatment of colon cancer, which include surgery, chemotherapy and radiation. While current treatments attack all fast-growing cells regardless of whether they're cancerous or not, immunotherapy selects only the cancerous cells to attack and kill.

In addition to immunotherapy and chemotherapy for colon cancer, there are also alternative and complementary therapies that some patients turn to after a diagnosis. Although they sound similar, they do not mean the same thing.

Alternative therapies are treatments that some choose instead of a doctor's medical treatment. These types of alternative treatments have typically not been tested scientifically to be safe and/or effective, and unfortunately, often postpone or take the place of scientifically tested treatments offer.

Complementary therapies, on the other hand, are used in conjunction with medically proven colon cancer treatments. These therapies are geared toward palliative care, or helping patients feel better. For example, meditation can reduce stress, peppermint tea can relieve nausea associated with colon cancer chemotherapy, and acupuncture has shown to relieve pain. According to the Mayo Clinic, no complementary or alternative therapies have been proven to cure colon cancer. However, certain treatments have given patients some relief of physical and emotional distress.

While the next great colon cancer treatment—immunotherapy for colon cancer—is not on the market just yet, there is promise of better, gentler treatment options. Experts encourage people with a colon cancer diagnosis to have an open dialogue with their doctor about the latest clinical trials, and about alternative and complementary therapies for colon cancer.

SNCC Offers Immunotherapy, Cancer Vaccines

The immune system is developed to help protect the body from infections and diseases. Immune cells are designed to travel through the body to detect harmful germs or cells that can cause infections. The immune system can also help protect the body from cancer in some ways; however, there are limits to what the immune system can do to fight cancer on its own.

When dealing with cancer, there are many treatment options available. Determining the best and most effective treatment for your cancer case can seem overwhelming, which is why you need a cancer expert on your side to answer questions. And one set of questions you may have may be about immunotherapy, which can include cancer vaccines.

“Immunotherapy is a constantly evolving treatment option for cancer,” said Dr. Jorge Perez with Sierra Nevada Cancer Center. “Its focus is on enhancing the immune system, enacting the body’s own defenses to fight off, or stop, the spread of cancer in the body.”

Immunotherapy can help treat a variety of cancers such as melanoma, breast, prostate and lung cancer.

Melanoma is the deadliest form of skin cancer and is responsible for the majority of skin cancer-related deaths. Breast cancer is the most common cancer diagnosed in women, whereas prostate cancer is the most common cancer among men and lung cancer is a leading cause of cancer deaths. The most common treatment options for these types of cancer may consist of surgery followed by radiation therapy, chemotherapy and targeted therapy.

But for many different types of cancer, immunotherapy has shown to be effective in a variety of clinical outcomes for patients with cancer. Immunotherapy can be used in conjunction with other cancer treatment options such as radiation or chemotherapy.

The most effective immunotherapy treatments for cancer consist of:

• cancer vaccines, which help trigger the immune system to attack tumor antigens;
• monoclonal antibodies (mAbs), where generated molecules or antibodies target cancer tumors by causing an immune response;
• Checkpoint inhibitors, which are target molecules that produce or enhance pre-existing anti-cancer immune responses to attack cancer cells.

Cancer Vaccines

There are two different types of cancer vaccines: vaccines that can prevent certain types of cancer and vaccines that can help treat cancer.

Similar to traditional vaccines used to prevent the chickenpox or the flu, cancer vaccines can help prevent or treat cancer. Preventive cancer vaccines are most effective for cancers known to be caused by infections, like the HPV vaccine, which helps prevent cervical, anal or throat cancers that can begin as an infection. Most cancers such as lung, prostate and breast cancers are not thought to be caused by infections and therefore can not be prevented by a cancer vaccine.

However, treatment cancer vaccines help boost the immune system to attack against cancer cells in the body. Take, for example, Sipuleucel-T (Provenge®), the only U.S. Food and Drug Administration (FDA) approved vaccine used to treat advanced prostate cancer that is no longer being helped by hormone therapy. Although the vaccine cannot cure prostate cancer, it has helped extend the lives of men with prostate cancer.

Monoclonal Antibodies

Monoclonal antibodies (mAbs) are man-made antibodies that specifically target a certain antigen, such as one that is found in cancer cells. When dealing with cancer, creating monoclonal antibodies can be difficult, especially when trying to identify the right antigen to attack. The FDA has approved more than a dozen mAbs to treat certain cancers. There are two main types of mAbs: naked mAbs, which are antibodies not attached to drugs or radioactive material, and conjugated mAbs, which are joined to a chemotherapy drug or a radioactive particle. Adoptive T cell therapy can be similar to mAbs, but instead, T cells are removed from a patient and then modified or treated to enhance activity. They are then transferred back into the patient to improve the immune system’s anti-cancer response.

Checkpoint Inhibitors

Checkpoints in the immune system are important to keep the immune system from attacking the normal cells in the body, but oftentimes cancer cells can find ways to avoid these checkpoints and avoid being attacked by the immune system. Checkpoint inhibitors can access these immune cells that need to be activated to start an immune response to recognize and attack cancer cells in the body. These inhibitors are particularly effective in treating advanced melanoma by blocking the protein that typically prevent the immune system from attacking itself, often shrinking tumors and helping patients live longer.

Although they cannot cure or prevent cancer, these immunotherapy treatments have helped certain patients with their specific cancer case. As researchers begin to understand and learn about the immune system and how it can be used to treat cancer, immunotherapy treatments are constantly changing and advancing. Some immunotherapy treatments focus on simply boosting the body’s immune system, whereas others are used to train the immune system to specifically attack cancer cells.